A Systems Approach to Rheumatoid Arthritis

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily attacks synovial joints. Despite the advances in diagnosis and treatment of RA, novel molecular targets are still needed to improve the accuracy of diagnosis and the therapeutic outcomes. Here, we present a systems approach that can effectively 1) identify core RA-associated genes (RAGs), 2) reconstruct RA-perturbed networks, and 3) select potential targets for diagnosis and treatments of RA. By integrating multiple gene expression datasets previously reported, we first identified 983 core RAGs that show RA dominant differential expression, compared to osteoarthritis (OA), in the multiple datasets. Using the core RAGs, we then reconstructed RA-perturbed networks that delineate key RA associated cellular processes and transcriptional regulation. The networks revealed that synovial fibroblasts play major roles in defining RA-perturbed processes, anti-TNF-α therapy restored many RA-perturbed processes, and 19 transcription factors (TFs) have major contribution to deregulation of the core RAGs in the RA-perturbed networks. Finally, we selected a list of potential molecular targets that can act as metrics or modulators of the RA-perturbed networks. Therefore, these network models identify a panel of potential targets that will serve as an important resource for the discovery of therapeutic targets and diagnostic markers, as well as providing novel insights into RA pathogenesis.

Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome

“…To assemble a merged dataset from diverse microarray and high throughput sequencing platforms, we applied a median-centering method followed by quantile scaling (MCQ) (18). Briefly, each dataset was normalized using the quantile method (19).…”

Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach

“…The lipid-associated cellular processes were enriched by the SM-dominant down-regulated cluster (C8). Because OA is not a systemic inflammatory disease, in contrast to RA, inflammatory gene signatures in peripheral blood mononuclear cells of OA patients are not significantly different from those of healthy individuals (16,17). We tried to validate differential expression of the selected 12 genes from FLS-and SM-dominant up-regulated clusters (C5 and C7) in independent RA-FLS and -SM samples obtained from different RA and OA patients and healthy controls using quantitative real-time PCR assays.…”

Patients with Rheumatoid Arthritis Identified as Potentially Suitable for Biosimilar Infliximabin Europe

“…Rheumatoid Arthritis (RA) is a chronic autoimmune disease that results in systemic inflammation and primarily attacks synovial joints [1].The disease morbidity is accompanied by a significant economic burden, in terms of direct healthcare costs (such as inpatient and outpatient costs) and indirect costs (such as costs associated productivity impairments) [2,3].Treatments for RA has evolved over time and now include NSAIDs, steroids, traditional disease-modifying antirheumatic drugs (DMARDs), and biological DMARDs [4]. The introduction of biologics revolutionized the treatment of RA; targeting specific components of the immune system allows efficient suppression of the pathologic inflammation cascade which causes joint destruction, thereby significantly alleviating patient disease burden [5].However, these biologics are expensive and their continued use over an extended period of time necessitate resource allocation at national level challenging to actively manage RA population and associated burden.…”